secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001493152-26-005966
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X appoints Mike Mulica as acting CEO; salary $450k, 50k RSUs; CFO Crolius gets 35k RSUs
--------------------------------------------------------------------------------

- Mike Mulica appointed acting CEO effective Feb 9, 2026; base salary raised to $450,000 retroactive to Jan 30.
- Mulica receives 50,000 RSUs vesting monthly over one year; COBRA reimbursement up to 12 months post-termination.
- CFO Clay Crolius amendment acknowledges Jan 23 asset sale as a triggering event for change in control.
- Crolius granted 35,000 RSUs vesting monthly over one year; COBRA reimbursement up to 6 months post-termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/0001493152-26-005966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226005966/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer